Loading CV, please wait...

CURRICULUM VITAE

DR. HEH CHOON HAN
DR. HEH CHOON HAN
Pharmacy Lecturer
Department of Pharmaceutical Chemistry
Faculty of Pharmacy
0379677835
ResearcherID
Scopus Author ID

BIOGRAPHY

Interested in computer-aided drug discovery. Developed Self-Evolving Peptide Algorithm (SEPA) for the better virtual screening of potential peptides towards specific drug target. SEPA is available here:

https://drive.google.com/drive/folders/1aEmCaSIkXdEJcAX8X1qPNJrzhBGSKv7p

or

https://github.com/RyanHeh/SEPA

 

ACADEMIC QUALIFICATION

  • PhD, (Pharmacy)
    Universiti Malaya (UM)
  • MSc.IT, (Information Systems, Technology & Management)
    Universiti Sains Malaysia (USM)
  • BPharm, (Pharmacy)
    Universiti Sains Malaysia (USM)

WORKING EXPERIENCE

  • 07 Mar 2013 -
    06 Mar 2014
    Provisionally Registered Pharmacist
    Hospital Putrajaya

ADMINISTRATIVE DUTIES

  • Head of Department
    02 Mar 2025 - 30 Jun 2025 (Department of Pharmaceutical Chemistry, Faculty of Pharmacy)
  • Head of Department
    01 Jan 2024 - 01 Mar 2025 (Department of Pharmaceutical Chemistry, Faculty of Pharmacy)
  • Head of Department
    16 Sep 2021 - 31 Dec 2023 (Department of Pharmaceutical Chemistry, Faculty of Pharmacy)
  • Head of Department
    16 Sep 2019 - 15 Sep 2021 (Department of Pharmaceutical Chemistry, Faculty of Pharmacy)
  • Module coordinator - Drug Literacy (MIB3019)
    10 Sep 2018 - 08 Sep 2019 (Department of Pharmacy, Faculty of Medicine)
  • Module coordinator - Pharmaceutical Product Development (MIB3017/MWEF3106)
    21 Jul 2017 - 20 Jul 2018 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Pharmaceutical Product Deveopment (MWEF3106)
    21 Jul 2016 - 20 Jul 2017 (Department of Pharmacy, Faculty of Medicine)
  • Committee member for Academic Quality Assurance
    21 Jul 2016 - 20 Jul 2017 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Basic Pharmaceutical Chemistry (MIB1001)
    21 Jul 2015 - 21 Jul 2016 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Physical Pharmacy (MIB1008/MWEF1107)
    22 Feb 2016 - 20 Jul 2016 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Pharmaceutical Product Development (MWEF3106)
    21 Jul 2015 - 20 Jul 2016 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Preparation of department documents for accreditation by the Pharmacy Board
    28 Aug 2014 - 31 Dec 2015 (Department of Pharmacy, Faculty of Medicine)
  • Quality Manager
    01 Sep 2015 - 31 Dec 2015 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Pharmacy Department Webpage
    28 Aug 2014 - 20 Jul 2015 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Physical Pharmcy (MWEF1107)
    28 Aug 2014 - 20 Jul 2015 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator - Pharmaceutical Product Development (MWEF3106)
    28 Aug 2014 - 20 Jul 2015 (Department of Pharmacy, Faculty of Medicine)

MEMBERSHIPS

  • ACTA TOPICA, ELSEVIER, REVIEWER
    Since 2014 (International)
  • PROFESSIONAL MEMBERSHIP OF SOCIETY OF COSMETIC SCIENTISTS (MALAYSIA), MEMBER
    2025 to 2025 (National)
  • PROFESSIONAL MEMBERSHIP OF MALAYSIA SOCIETY OF COSMETIC SCIENTIST, MEMBER
    2023 to 2024 (National)

AWARD AND STEWARDSHIP

  • Certificate of Excellent Service
    2025, Universiti Malaya
  • Excellence Service Award
    2020, Universiti Malaya
  • Certificate of Excellent Service
    2018, Universiti Malaya
  • Certificate of Excellent Service
    2017, Universiti Malaya

PUBLICATIONS

Article in Journal
WoS
  1. Anasamy, T; Foo, YY; Saw, WS; Kwa, YC; Wei, CC; Heh, CH; Chee, CF; Kiew, LV; Chung, LY (2026). Multifaceted anticancer mechanisms of tribenzyltin carboxylates: DNA minor groove targeting and inhibition of key enzymes in DNA replication, nucleotide synthesis, and redox homeostasis, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. . doi:10.1007/s00210-025-04890-6
  2. Wei, CC; Heh, CH; Chin, SP (2026). Selective Stabilization of LRRK2 Kinase Conformations Reveals Distinct Modes of Action for Type I and II Inhibitors, CELL BIOCHEMISTRY AND BIOPHYSICS. . doi:10.1007/s12013-025-01877-1
  3. Wei, CC; Heh, CH; Chin, SP (2025). Exploring the Impact of LRRK2 WD40 G2294R Mutation on Conformation and Dimerisation Dynamics: Insights From Molecular Dynamics Simulation, JOURNAL OF CELLULAR BIOCHEMISTRY. 126(2). doi:10.1002/jcb.70011
  4. Wei, CC; Heh, CH; Lit, LC; Chin, SP (2025). Comparative Molecular Dynamics Reveals How LRRK2 Inhibitors Distinguish G2019S from Wild-Type, NEUROCHEMICAL RESEARCH. 50(4). doi:10.1007/s11064-025-04520-w
  5. Tasnim, Jarin; Hashim, Najihah Mohd; Han, Heh Choon (2024). A comprehensive review on potential drug-drug interactions of proton pump inhibitors with antidiabetic drugs metformin and DPP-4 inhibitors, CELL BIOCHEMISTRY AND FUNCTION. 42(2). doi:10.1002/cbf.3967
  6. Chan, Yi Wei; Tan, Choo Hock; Heh, Choon Han; Tan, Kae Yi (2023). An immunoinformatic approach to assessing the immunogenic capacity of alpha-neurotoxins in elapid snake venoms, FRONTIERS IN PHARMACOLOGY. 14. doi:10.3389/fphar.2023.1143437
  7. Tan, Ke Han; Chin, Sek Peng; Heh, Choon Han (2022). Automated in silico EGFR Peptide Inhibitor Elongation using Self-evolving Peptide Algorithm, CURRENT COMPUTER-AIDED DRUG DESIGN. 18(2), 150-158. doi:10.2174/1573409918666220516144300
  8. Tan, Wan Chein; Othman, Shatrah; Lim, See Khai; Rashid, Nurshamimi Nor; Heh, Choon Han (2022). A Reverse Structure-based Design of HPV E7 Inhibitor, CURRENT COMPUTER-AIDED DRUG DESIGN. 18(4), 318-325. doi:10.2174/1573409918666220509214449
  9. Wong, Chen Yuan; Leong, Kok Hoong; He, Xuemei; Zheng, Fengjing; Sun, Jian; Wang, Zhenxing; Heh, Choon Han; Kong, Kin Weng (2022). Phytochemicals of six selected herbal plants and their inhibitory activities towards free radicals and glycation, FOOD BIOSCIENCE. 46. doi:10.1016/j.fbio.2022.101557
  10. Zaidi, Norburhanuddin Johari; Abdullah, Adib Afandi; Heh, Choon Han; Lin, Chun-Hung; Othman, Rozana; Ahmad Fuaad, Abdullah Al Hadi (2022). Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations, MOLECULES. 27(10). doi:10.3390/molecules27103233
  11. Abdulwahab, M. K., Tan, K. H., Dzulkeflee, R., Leong, K. H., Heh, C. H., & Ariffin, A. (2021). In-silico Studies of the Antiproliferative Activity of New Anilinoquinazoline Derivatives Against NSCLC Cells. Journal of Molecular Structure, 1228, 13. doi: 10.1016/j.molstruc.2020.129786
  12. Anasamy, T., Chee, C. F., Wong, Y. E. F., Heh, C. H., Kiew, L. V., Lee, H. B., & Chung, L. Y. (2021). Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectives. Applied Organometallic Chemistry, 35(2), 33. doi: 10.1002/aoc.6089
  13. Kiew, L. V., Chang, C. Y., Huang, S. Y., Wang, P. W., Heh, C. H., Liu, C. T., . . . Chang, C. C. (2021). Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors. Biosensors & Bioelectronics, 183, 10. doi: 10.1016/j.bios.2021.113213
  14. Lim, S. K., Othman, R., Yusof, R., & Heh, C. H. (2021). Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes. Chemical Biology & Drug Design, 97(1), 28-40. doi: 10.1111/cbdd.13756
  15. Shi, H., Ishikawa, R., Heh, C. H., Sasaki, S., & Taniguchi, Y. (2021). Development of MTH1-Binding Nucleotide Analogs Based on 7,8-Dihalogenated 7-Deaza-dG Derivatives. International Journal of Molecular Sciences, 22(3), 13. doi: 10.3390/ijms22031274
  16. Abdullah, A. A., Lee, Y. K., Chin, S. P., Lim, S. K., Lee, V. S., Othman, R., . . . Heh, C. H. (2020). Discovery of Dengue Virus Inhibitors. Current Medicinal Chemistry, 27(30), 4945-5036. doi: 10.2174/0929867326666181204155336
  17. Abdulwahab, M. K., Dzulkeflee, R., Han, T. K., Ruslan, R. A., Leong, K. H., Heh, C. H., & Ariffin, A. (2020). Synthesis, In Vitro Antiproliferative Activity, and In Silico Studies of New Anilinoquinazoline Derivatives as Potential AntitumorAgents. Russian Journal of General Chemistry, 90(12), 2410-2418. doi: 10.1134/s1070363220120294
  18. Thavoncharoensub, N., Maruyama, K., Heh, C. H., Leong, K. H., Shi, H., Shigematsu, Y., . . . Taniguchi, Y. Synthesis of gamma-N-modified 8-oxo-2-deoxyguanosine triphosphate and its characterization. Nucleosides Nucleotides Nucleic Acids, 12. doi:10.1080/15257770.2019.1586919
  19. Bujang, N. B., Chee, C. F., Heh, C. H., Abd Rahman, N., Buckle, M. J. C. (2017). Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014-16. Food Additives and Contaminants Part a-Chemistry Analysis Control Exposure Risk Assessment, 34(7), 1101-1109. doi: 10.1080/19440049.2017.1336674
  20. Gan, C. S., Lee, Y. K., Heh, C. H., Rahman, N. A., Yusof, R., Othman, S. (2017). The synthetic molecules YK51 and YK73 attenuate replication of dengue virus serotype 2. Tropical Biomedicine, 34(2), 270-283.
  21. Lim, See K.; Othman, Rozana; Yusof, Rohana; Heh, Choon H. (2017). Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization, CURRENT COMPUTER-AIDED DRUG DESIGN. 13(2), 160-169. doi:10.2174/1573409912666161130122622
  22. Lee, Ching Chin; Harun, Fatimah; Jalaludin, Muhammad Yazid; Heh, Choon Han; Othman, Rozana; Junit, Sarni Mat (2015). Prevalence of c.2268dup and detection of two novel alterations, c.670_672del and c.1186C>T, in the TPO gene in a cohort of Malaysian-Chinese with thyroid dyshormonogenesis, BMJ OPEN. 5(1). doi:10.1136/bmjopen-2014-006121
  23. Lee, C. C., Harun, F., Jalaludin, M. Y., Heh, C. H., Othman, R., Kang, I. N., Junit, S. M. (2014). Variable Clinical Phenotypes in a Family with Homozygous c.1159G > A Mutation in the Thyroid Peroxidase Gene, Hormone Research in Paediatrics. 81(5), 356-360
  24. Lee, Ching Chin; Harun, Fatimah; Jalaludin, Muhammad Yazid; Heh, Choon Han; Othman, Rozana; Kang, In Nee; Junit, Sarni Mat (2014). Variable Clinical Phenotypes in a Family with Homozygous c.1159G>A Mutation in the Thyroid Peroxidase Gene, HORMONE RESEARCH IN PAEDIATRICS. 81(5), 356-360. doi:10.1159/000359922
  25. Heh, Choon H.; Othman, Rozana; Buckle, Michael J. C.; Sharifuddin, Yusrizam; Yusof, Rohana; Rahman, Noorsaadah A. (2013). Rational Discovery of Dengue Type 2 Non-Competitive Inhibitors, CHEMICAL BIOLOGY & DRUG DESIGN. 82(1), 1-11. doi:10.1111/cbdd.12122
  26. Lee, C. C., Harun, F., Jalaludin, M. Y., Heh, C. H., Othman, R., Junit, S. M. (2013). A Novel, Homozygous c.1502T G (p.Val501Gly) Mutation in the Thyroid peroxidase Gene in Malaysian Sisters with Congenital Hypothyroidism and Multinodular Goiter, International Journal of Endocrinology. (7)
  27. Lee, Ching Chin; Harun, Fatimah; Jalaludin, Muhammad Yazid; Heh, Choon Han; Othman, Rozana; Junit, Sarni Mat (2013). A Novel, Homozygous c.1502T>G (p.Val501Gly) Mutation in the Thyroid peroxidase Gene in Malaysian Sisters with Congenital Hypothyroidism and Multinodular Goiter, INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. 2013. doi:10.1155/2013/987186
  28. Eng-Chong, T., Yean-Kee, L., Chin-Fei, C., Choon-Han, H., Sher-Ming, W., Li-Ping, C. T., Gen-Teck, F., Khalid, N., Abd Rahman, N., Karsani, S. A., Othman, S., Othman, R., Yusof, R. (2012). Boesenbergia rotunda: From Ethnomedicine to Drug Discovery, Evidence-Based Complementary and Alternative Medicine. (Review), 1741-427X.
  29. Eng-Chong, Tan; Yean-Kee, Lee; Chin-Fei, Chee; Choon-Han, Heh; Sher-Ming, Wong; Li-Ping, Christina Thio; Gen-Teck, Foo; Khalid, Norzulaani; Abd Rahman, Noorsaadah; Karsani, Saiful Anuar; Othman, Shatrah; Othman, Rozana; Yusof, Rohana (2012). Boesenbergia rotunda: From Ethnomedicine to Drug Discovery, EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2012. doi:10.1155/2012/473637
  30. Rothan, H. A., Han, H. C., Ramasamy, T. S., Othman, S., Abd Rahman, N., Yusof, R. (2012). Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1, Bmc Infectious Diseases. 12, Article
  31. Rothan, Hussin A.; Han, Heh Choon; Ramasamy, Thamil Selvee; Othman, Shatrah; Abd Rahman, Noorsaadah; Yusof, Rohana (2012). Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1, BMC INFECTIOUS DISEASES. 12. doi:10.1186/1471-2334-12-314
Scopus
  1. Anasamy T., Foo Y.Y., Saw W.S., Kwa Y.C., Wei C., Heh C.H., Chee C.F., Kiew L.V., Chung L.Y. (2026). Multifaceted anticancer mechanisms of tribenzyltin carboxylates: DNA minor groove targeting and inhibition of key enzymes in DNA replication, nucleotide synthesis, and redox homeostasis, Naunyn Schmiedeberg S Archives of Pharmacology. . doi:10.1007/s00210-025-04890-6
Others
  1. Thavoncharoensub N, Maruyama K, Heh CH, Leong KH, Shi H, Shigematsu Y, Sasaki S, Taniguchi Y (2019) Synthesis of c-N-modified 8-oxo-2 -deoxyguanosine triphosphate and its characterization. Nucleosides, Nucleotides and Nucleic Acids. 38(8), 578-589.
  2. Bujang, N. B., Chee, C. F., Heh, C. H., Rahman, N. A., & Buckle, M. J. (2017). Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market in 2014-2016. Food Additives & Contaminants: Part A, null-null. doi: 10.1080/19440049.2017.1336674
  3. Gan, C. S., Lee, Y. K., Heh, C. H., Rahman, N. A., Yusof, R., & Othman, S. (2017). The synthetic molecules YK51 and YK73 attenuate replication of dengue virus serotype 2. Tropical Biomedicine, 34(2), 270-283.
  4. Gan, C. S., Lim, S. K., Chee, C. F., Yusof, R., & Heh, C. H. (2017). Sofosbuvir as treatment against dengue? Chem Biol Drug Des. doi: 10.1111/cbdd.13091
  5. Lim, S., Othman, R., Yusof, R., & Heh, C. (2016). Rational drug discovery of HCV helicase inhibitor: Improved docking accuracy with multiple seedings of Autodock Vina and in situ minimization. Curr Comput Aided Drug Des., 13(2), 160-169.
  6. Ching Chin Lee, Fatimah Harun, Muhammad Yazid Jalaludin, Choon Han Heh, Rozana Othman, Sarni Mat Junit. Prevalence of c.2268dup and detection of two novel alterations, c.670_672del and c.1186C>T, in the TPO gene in a cohort of Malaysian Chinese with thyroid dyshormonogenesis. BMJ Open 2015;5:e006121. doi:10.1136/bmjopen- 2014-006121
  7. Ching Chin Lee, Fatimah Harun, Muhammad Yazid Jalaludin, Choon Han Heh, Rozana Othman, In Nee Kang, and Sarni Mat Junit. Variable clinical phenotypes in a family with homozygous c.1159G>A mutation in the thyroid peroxidase gene. Hormone Research in Paediatrics (2014) 81: 356-360 DOI:10.1159/000359922)
  8. Heh, C. H., Othman, R., Buckle, M. J., Sharifuddin, Y., Yusof, R., & Rahman, N. A. (2013). Rational discovery of dengue type 2 non-competitive inhibitors. Chem Biol Drug Des, 82(1), 1-11. doi: 10.1111/cbdd.12122
  9. Lee, C. C., Harun, F., Jalaludin, M. Y., Heh, C. H., Othman, R., & Mat Junit, S. (2013). A Novel, Homozygous c.1502T>G (p.Val501Gly) Mutation in the Thyroid peroxidase Gene in Malaysian Sisters with Congenital Hypothyroidism and Multinodular Goiter. Int J Endocrinol, 2013, 987186.
  10. Eng-Chong, T., Yean-Kee, L., Chin-Fei, C., Choon-Han, H., Sher-Ming, W., Li-Ping, C. T., . . . Yusof, R. (2012). Boesenbergia rotunda: From Ethnomedicine to Drug Discovery. Evid Based Complement Alternat Med, 2012, 473637.
  11. Rothan, H., Han, H. C., Ramasamy, T. S., Othman, S., Rahman, N. A., & Yusof, R. (2012). Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infectious Diseases, 12(1), 314.
Chapter in Books
  1. Heh, C.H., Othman, R., Yusof, R., Rahman, N. A. (2016) Rational Drug Discovery: Virtual Screening of DEN-2 Non-competitive Inhibitors. In Software and Techniques for Bio-Molecular Modelling, pp. 1-9. Austin Publishing Group.

RESEARCH PROJECT

National
  1. 2022 - 2026, Fundamental Research Grant Scheme (FRGS)
    Investigating Factors Affecting Aptamer?s Conformation And Target Sensitivity At The Aptamer-graphene Interface And Mechanism Description For Biosensing Applications ( Co-Researcher)
  2. 2023 - 2026, Fundamental Research Grant Scheme (FRGS)
    Deep Learning In Molecular Descriptors Mining And Optimization For Drug-potentials Targeting G Protein-coupled Receptors ( Co-Researcher)
  3. 2019 - 2023, Fundamental Research Grant Scheme (FRGS)
    Investigations Into The Poor Neutralization Efficacy Of Cobra Antivenom Against Lethal Cobra Neurotoxins Through In Vitro, In Vivo And In Silico Studies ( Co-Researcher)
  4. 2019 - 2022, Fundamental Research Grant Scheme (FRGS)
    A Mechanistic Study To Identify The Upstream Therapeutic Target Of Tribenzyltin Carboxylates For Improving Cancer Chemotherapy ( Principal Investigator(PI))
  5. 2019 - 2022, Fundamental Research Grant Scheme (FRGS)
    Unravelling The Antineoplastic Mechanism Of Anilinoquinazoline Compound In Lung Cancer Stem Cells And Zebrafish ( Co-Researcher)
  6. 2018 - 2021, RU Geran - Fakulti Program
    Multiscale Refinement Of Cryo-electron Microscopy Data For Structural Analysis And Mechanism Study Of Biological Macromolecules ( Co-Researcher)
  7. 2019 - 2021, Fundamental Research Grant Scheme (FRGS)
    In Silico Self-evolving Peptides Algorithm For The Discovery Of Potential Peptide Inhibitor Against Alpha-amylase And Alpha-glucosidase ( Principal Investigator(PI))
  8. 2016 - 2019, Postgraduate Research Grant (PPP) - Research
    Rational Discovery of Novel Hepatitis C Virus Inhibitors--An in silico approach targeting HCV serine protease and helicase ( Principal Investigator(PI))
  9. 2017 - 2019, Geran Penyelidikan Universiti Malaya (UMRG Programme) - AFR (Frontier Science)
    Insight Into The Binding Mechanism Of Quinazoline Derivatives Against Non-mutated And Mutated Egfrs ( Principal Investigator(PI))
  10. 2017 - 2018, Bantuan Khas Penyelidikan (BKP Special)
    Rational Discovery Of Novel Hepatitis C Virus Inhibitors ( Principal Investigator(PI))
  11. 2015 - 2017, Postgraduate Research Grant (PPP) - Research
    DEVELOPMENT OF A LIQUID CHROMATOGRAPHY MASS SPECTROMETRY (LCMS) METHOD FOR PHOSPHODIESTERASE-5 INHIBITORS ( Principal Investigator(PI))
  12. 2014 - 2016, Bantuan Kecil Penyelidikan (BKP)
    Discovery of Novel Inhibitors for Hepatitis C Virus via Virtual Screening ( Principal Investigator(PI))
Private
  1. 2015 - 2017, Private Funding
    Small Peptide Design For Anti Inflammatory Activity ( Principal Investigator(PI))
International
  1. 2021 - 2027, International Funding
    Satreps : The Trilateral Collaboration Project For Anti-infectious Disease Drug Development: From Lead Optimization To Preclinical Testing ( Co-Researcher)

CONSULTANCY PROJECT

  • Facial Image Analysis Software 2.0, WINNOX COSMECEUTICS SDN BHD
    01 Jan 2024 - 31 Dec 2024 (National)
  • Eye Dark Circle Detection Software, Wipro Manufacturing Services Sdn. Bhd., Consultant
    01 Oct 2017 - 01 Oct 2018 (National)

PAPER PRESENTED

Oral Presenter
  1. Self-Evolving Peptide Algorithm, Breakfast@UMHealth, Visibility, Information and Communication Unit, Faculty of Medicine (University) (12 Jul 2023 - 12 Jul 2023)
Poster Presenter
  1. Insight into the Binding Mechanism of Quinazoline Derivatives against Non-mutated EGFRs for the Discovery of Anti-cancer Agent towards Non-small-cell Lung Cancer (Tan Ke Han), University Malaya Research Carnival, UM (University) (15 Nov 2018 - 16 Nov 2018)
  2. Rational Drug Discovery of Potential HCV Helicase Inhibitors, International Symposium on Grids & Clouds (ISGC) 2017, Academia Sinica (International) (05 Mar 2017 - 10 Mar 2017)
  3. Rational Discovery of Dengue Inhibitors, 7th HOPE Meeting, JSPS (International) (02 Mar 2015 - 06 Mar 2015)
Presenter
  1. Fragment-based Anti-zika Discovery, Nobelist Mindset Workshop 2016, UKM (National) (19 Sep 2016 - 23 Sep 2016)
Others
  1. Rational discovery of anti-hepatitis c viral agent, Kyushu University UM Pharmacy Symposium 2018, Pharmacy Department, Faculty Medicine, University Malaya (International) (28 Nov 2018 - 28 Nov 2018)

ACADEMIC/ PROF. SERVICES

Evaluation
  1. (2016) Antimicrobial Peptide Susceptibility of Burkholderia Pseudomallei by Lee Lyn Fay, (Internal Examiner)
  2. (2016) Drug Design and Synthesis of COX-2 Selective Inhibitors as Potential NSAIDs by Abbeer A. Abdul Kader (SHC120031), (Internal Examiner)
  3. (2015) Drug Design and Synthesis of COX-2 Selective Inhibitors as Potential NSAIDs by Abbeer A. Abdul Kader (SHC120031), (Internal Examiner)
  4. (2015) Reviewer for MPS-PSC Abstracts, (Reviewer)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2025) INTEGRATIVE PHYTOCHEMICAL AND NETWORK PHARMACOLOGY APPROACH FOR THE DISCOVERY AND VALIDATION OF ANTIDIABETIC AGENTS FROM SELECTED MALAYSIAN EDIBLE HERBS (ULAM), JARIN TASNIM
  2. (2025) AI-DRIVEN DISCOVERY OF COX-2 SELECTIVE INHIBITORS, WU ZIQIAO
  3. (2025) PEPTIDES GENERATION ALGORITHM TARGETING CANCER CELL SURFACE PROPERTIES: IN SILICO & IN VITRO STUDY, ZIRUI WANG
  4. (2025) INTEGRATIVE APPROACH TOWARDS THE DEVELOPMENT OF SPIROOXINDOLES AS POTENTIAL DENGUE VIRUS PROTEASE TYPE 2 INHIBITORS, KE HAN TAN
  5. (2023) Investigating the Neutralisation Efficacy of an Elapid Antivenom and Factors Affecting the Immunogenic Capacity of Alpha-Neurotoxins, CHAN YI WEI
  6. (2020) SYNTHESIS OF NEW ANILINOQUINAZOLINE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS: ANTIPROLIFERATIVE ACTIVITY, MOLECULAR DOCKING AND MOLECULAR DYNAMICS STUDIES, MUHAMMAD KUMAYL BIN ABDUL WAHAB
  7. (2019) Rational Discovery of Novel NS3 Enzyme Inhibitors for Genotype 3 Hepatitis C Virus, LIM SEE KHAI
  8. (2015) Rational Discovery of Novel Hepatitis C Virus Inhibitors, Lim See Khai
Master
  1. (2025) DEVELOPMENT OF A KNIME BASED VIRTUAL SCREENING PIPELINE FOR ENHANCED PREDICTION OF DENGUE INHIBITORS, FARHAN AHMAD
  2. (2025) Discovery of potential anticancer L-peptide targeting MDA-MB-231 cell surface using self-evolving peptide algorithm., SUN HAO
  3. (2024) Evaluation of Potential Drug-Drug Interactions between Omeprazole and Anti-Diabetic Drug Linaglipitin: In Silico and In Vitro Analysis, JARIN TASNIM
  4. (2024) Discovery of Potential LRRK2 Inhibitors Through Al-Driven In Silico Methods for Parkinson's Disease, CHUANCHENG WEI
  5. (2021) IN SILICO STUDIES OF COMPETITIVE AND NON-COMPETITIVE EGFR-TK INHIBITORS IN LUNG CANCER, TAN KE HAN
  6. (2021) A REVERSED STRUCTURE-BASED PEPTIDE DESIGN OF HUMAN PAPILLOMAVIRUS E7 INHIBITOR, TAN WAN CHEIN
  7. (2016) In Silico Design of Short Chain Peptide Inhibitor, ADIB AFANDI BIN ABDULLAH
  8. (2016) SIMULTANEOUS DETERMINATION OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITORS AND THEIR ANALOGUES IN SEXUAL ENHANCEMENT PRODUCTS, NUR BAIZURA BINTI BUJANG
  9. (2015) DEVELOPMENT OF A LIQUID CHROMATOGRAPHY MASS SPECTROMETRY (LC/MS) METHOD FOR SIMULATANEOUS DETERMINATION OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITORS, Nur Baizura Binti Bujang

TEACHING

Master
  1. (2024) OQB7005 - Pharmaceutical Bioinformatics
  2. (2023) OQB7006 - Advanced Medicinal Chemistry
Bachelor
  1. (2018) MIB2001 - Medicinal Chemistry
  2. (2018) MIB3019 - Drug Literacy
  3. (2016) MIB1008 - Physical Pharmacy
  4. (2016) MWEF1107 - Physical Pharmacy
  5. (2015) MWEF4104 - Hospital Pharmacy Services
  6. (2014) MWEF3106 - Pharmaceutical Product Development
  7. (2014) MWEF4103 - Clinical Pharmacy and Pharmacotherapy Ii

PATENT/ IPR

  • Self-evolving Peptide Algorithm
    COPYRIGHT
  • A NOVEL DENGUE PROTEASE ASSAY KIT
    Patent (National)

SOCIAL RESPONSIBILITY ACTIVITIES

  • SCIENTIFIC COMMITEE MEMBER OFTHE MALAYSIAN PHARMACISTS SOCIETY NATIONAL PHARMACISTS CONVENTION 2025, (25 Jul 2025 - 27 Jul 2025) (National)
  • PEMPAMER BAGI PROGRAM STAR EDUCATION FAIR 2024, (05 May 2024 - 05 May 2024) (National)
  • SCIENTIFIC COMMITTEE MEMBER OF INTERNATIONAL CONFERENCE ON DRUG DISCOVERY AND TRANSLATIONAL MEDICINE 2023, (04 Dec 2023 - 08 Dec 2023) (International)
  • PEMPAMER DI KARNIVAL PENDIDIKAN KERJAYA KOLEJ MATRIKULASI PERAK 2022/2023, (10 Nov 2022 - 13 Nov 2022) (National)